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ABSTRACT 
The development and normal function of prostate tissue depends on signalling interactions between 
stromal and epithelial compartments.  Development of a prostate microtissue composed of these two 
components can help identify substance exposures that could cause adverse effects in humans as part 
of a non-animal risk assessment.  In this study, prostate microtissues composed of human derived 
stromal (WPMY-1) and epithelial (RWPE-1) cell lines grown in scaffold-free hydrogels were 
developed and characterized using immunohistochemistry, light microscopy, and qRT-PCR.  Within 5 
days after seeding, the microtissues self-organized into spheroids consisting of a core of stromal 
WPMY-1 cells surrounded by epithelial RWPE-1 cells.  The RWPE-1 layer is reflective of 
intermediate prostatic epithelium, expressing both characteristics of the luminal (high expression of 
PSA) and basal (high expression of cytokeratins 5/6 and 14) epithelial cells.  The response of the 
microtissues to an androgen (dihydrotestosterone, DHT) and an anti-androgen (flutamide) was also 
investigated.  Treatment with DHT, flutamide or a mixture of DHT and flutamide indicated that the 
morphology and self-organization of the microtissues is androgen dependent.  qRT-PCR data showed 
that a saturating concentration of DHT increased the expression of genes coding for the estrogen 
receptors (ESR1 and ESR2) and decreased the expression of CYP1B1 without affecting the expression 
of the androgen receptor. With further development and optimization RWPE-1/WPMY-1 microtissues 
can play an important role in non-animal risk assessments. 
 
HIGHLIGHTS 
 
- Non-animal risk assessment requires innovative cellular models representative of human 
biology 
- RWPE-1 and WPMY-1 cells form microtissues when grown in scaffold-free hydrogels 
- Microtissues represent an early stage of human prostate development 
- Morphological and molecular biomarkers are responsive to androgens/anti-androgens 
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1. INTRODUCTION 
The risk assessment of endocrine active chemicals (EACs) relies heavily on the use of in vitro 
screening tests for endocrine activity.  Most in vitro tests for endocrine activity are based on detecting 
a biological response (e.g. transcriptional activation) that may or may not lead to an adverse response 
in vivo.  Assays that provide a functional response to endocrine active chemicals (e.g. inhibition of 
steroidogenesis) most often use two-dimensional (2D) culture systems that are not necessarily 
representative of the biology of normal endocrine sensitive tissues in vivo. These in vitro data are used 
to prioritize chemicals for subsequent in vivo testing, with the aim of identifying whether the observed 
endocrine activity gives rise to any adverse effects, and to characterize the dose-response of any 
effects seen.  The need to generate these confirmatory animal data is therefore driven in part by 
limitations of the existing reductionist in vitro systems, which cannot differentiate between endocrine 
activity and adversity in a physiologically-relevant way (Dent et al., 2015). 
The desire to reduce and to ultimately end the use of animal safety assessments has placed increased 
emphasis on the development of in vitro systems that are more representative of in vivo biology.  It 
has long been accepted that three-dimensional (3D) cultures have the potential to improve the 
physiological relevance of in vitro experiments and to provide data that are more reflective of tissue 
responses in whole organisms (Pampaloni, Reynaud and Stelzer, 2007).  The development of a non-
animal approach to the risk assessment of EACs therefore requires the development of 3D cell 
cultures of endocrine-sensitive tissues and identification of molecular and morphological biomarkers 
that are reflective of perturbed functioning of that tissue in the whole organism.  Our ambition is to 
use these tools in an exposure-led safety assessment to enable robust safety decision making for EACs 
without use of animals. 
The development of the prostate is under influence of the hypothalamus-pituitary-gonadal axis that 
may be affected by exposure to androgens and anti-androgens, and development of an in vivo-like 
microtissue model representing the normal prostate microenvironment would greatly advance our 
ability to perform non-animal risk assessments for EACs.  Because the development and function of 
the prostate is dependent on the close interaction between stromal and epithelial cells (Hayward, 
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Rosen and Cunha, 1997), physiologically-relevant 3D cultures of prostate cells require both cell types 
to be present.  Furthermore, androgenic stimulation of the stroma is an important trigger for 
development of the epithelium during organogenesis (Cunha, Donjacour and Sugimura, 1986; Peng 
and Joyner, 2015).  We therefore developed a 3D co-culture prostate microtissue model composed of 
commercially-available epithelial (RWPE-1) and stromal (WPMY-1) cell lines.  The RWPE-1 cell 
line was established from normal human prostate epithelial cells which were immortalized with 
human papillomavirus 18, and expresses both androgen receptor (AR) and prostate specific antigen 
(PSA) (Bello et al., 1997).  The WPMY-1 myofibroblast cell line was derived from the same prostate, 
and immortalized with the SV40 large-T antigen (Webber et al., 1999).  The objectives of this work 
are to: 1) assess whether RWPE-1 and WPMY-1 cells form microtissues when grown in scaffold-free 
hydrogels, 2) investigate the characteristics and function of the resulting microtissues using different 
molecular and imaging techniques, and 3) evaluate the response of this prostate co-culture model to 
androgenic and anti-androgenic responses. 
 
2. MATERIALS AND METHODS 
2.1. Cell Culture  
RWPE-1 and WPMY-1 cells were obtained from ATCC (CRL-11609 and CRL-2854 respectively).  
RWPE-1 cells were maintained in keratinocyte serum free medium (K-SFM) supplemented with 0.05 
mg/ml bovine pituitary extract (BPE) and 5 ng/ml epidermal growth factor (EGF). WPMY-1 cells 
were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 5% fetal 
bovine serum (FBS), 1 mM sodium pyruvate, 4 mM L-glutamine and 1% penicillin streptomycin. 
Medium was changed every 2-3 days. Co-cultures were seeded at an equal ratio of the cell types and 
grown in a 1:1 mixture of K-SFM and DMEM, containing 2.5% FBS, 0.025 mg/ml BPE and 2.5 
ng/ml EGF, 0.5 mM sodium pyruvate, 2 mM L-glutamine, and 0.5% penicillin streptomycin.  A lower 
level of serum (1.25%) which was charcoal stripped was used in experiments where androgenic 
(DHT) or anti-androgenic (flutamide) test substances were administered to reduce interference from 
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background hormonal stimulation.  Cells were grown in an incubator at a temperature of 37°C at 5% 
CO2. 
2.2. 3D culture methods 
Hydrogels containing 2% agarose were cast from a 12-256 Small Spheroid mould from Microtissues 
Inc., RI, USA and placed into 12-well tissue culture plates.  In the initial characterization, cells were 
seeded at a total density of 3×10
5
 cells/ml (approx. 222 cells/microtissue, 1:1 ratio of each cell type) 
and cultured for 7-days.  Medium was changed every 2-3 days.  Cells were seeded at a total density of 
6×10
5
 cells/ml (approx. 445 cells/microtissue, 1:1 ratio of cell type) for 4-days. 
 
2.3. Treatment with dihydrotestosterone (DHT) and flutamide  
The response of microtissues to exposure to (anti-)androgenic substances was assessed by exposing 
the microtissues to DHT (Sigma, A8380) or flutamide (Sigma, F9397) in DMSO to achieve final 
concentrations in media of 10 nM or 10 µM respectively, and to a 1:1 mixture of these treatments for 
4-days.  Control microtissues were cultured for the same duration in plain medium containing the 
same concentration of DMSO (0.1%) as the treated microtissues.  The treatment concentrations were 
selected to represent a saturating concentration of the ligand and the antagonist.  Furthermore, 10 nM 
DHT is similar to the tissue concentration of DHT in cases of benign prostatic hypertrophy (Titus et 
al., 2005) 
 
2.4. Live cell imaging 
Cell imaging was performed using a Perkin Elmer Opera Phenix™ high content imaging system.  To 
enable the organization of the microtissue to be monitored over time, each cell line was tagged with a 
different fluorescent tracer.  WPMY-1 cells were tagged with a green tracer (Life Technologies 
C7025) and RWPE-1 cells with a red tracer (Life Technologies C34552).  Confocal images were 
collected following treatment with DHT, flutamide or DHT+flutamide over consecutive days. 
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2.5. Immunohistochemistry 
Immunohistochemistry (IHC) was performed to see if the proteins expressed in the microtissues 
reflected their expression in normal prostate tissue.  To characterize protein expression agarose 
hydrogels containing microtissues were fixed in 70% ethanol for at least 24-hours.  The gels were 
then embedded in paraffin, sectioned at 5 µm and mounted on glass slides.  Slides were stained with 
hematoxylin and eosin (H&E) or subjected to immunohistochemical staining.  After sections were de-
paraffinized and hydrated antigen retrieval was performed for cytokeratins (CK) by steaming for 20 
minutes in Tris/EDTA buffer composed of 1.21 g Trizma® base (Sigma T1503) and 0.37g EDTA 
(Sigma E5134) in 1L purified water.  Sections were then incubated with an Avidin/Biotin Block Kit 
(Vector Laboratories SP-2100) according to the manufacturer's instructions and blocked in 10% goat 
serum (Sigma G9023), 1% bovine serum albumin (BSA) (Sigma A2153) in a solution of 0.05% 
Tween 20 (Sigma P9416) in physiologically buffered saline (PBS-T) for 20-minutes.  Slides were 
incubated for 1-hour at room temperature with the appropriate antibody diluted in blocking solution at 
the following concentrations: Anti-CK5/6 (Dako M7237 at 1:100); Anti-CK8 (Sigma SAB5500133 at 
1:50); Anti-CK14 (Sigma SAB5500124 at 1:250); Anti-CK18 (Dako M7010 at 1:50); Anti-CK19 
(Dako M0888 at 1:100); Anti-vimentin (Sigma V6630 at 1:40).  Following washes in PBS-T, samples 
were incubated with the appropriate biotinylated secondary antibody (either goat anti-mouse IgG 
(Sigma B0529) or goat anti-rabbit (Sigma B8895)) for 1-hour at room temperature and subsequent 
incubation with Avidin/Biotin Peroxidase Complex Kit (Vector Laboratories PK-6100) as per 
manufacturer's instructions.  Antibody expression was detected using the DAB Kit (Vector 
Laboratories SK-4100), sections were counterstained with hematoxylin, cleared and coverslipped.  
Where timepoints or treatments are compared, staining was conducted under the same conditions at 
on the same day.  For interpretation of morphology, an estimate of the ratio of epithelium to stromal 
cells was used. 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
2.6. Gene expression 
The expression of selected genes was evaluated in the microtissues over time, and the effect of 
treatment with DHT, flutamide or a mixture of DHT and flutamide on their relative expression was 
explored.  These included genes coding for the androgen receptor (AR), estrogen receptor 1 and 2 
(ER-α and ER-β) and cytochrome p450 1B1 (CYP1B1), a potential biomarker for the development of 
prostate cancer (Ragavan et al., 2004; Chang et al., 2017).  Each quantitative real-time PCR (qRT-
PCR) experiment consisted of 4 biological replicates (independent experiments) to ensure data 
reproducibility.  Microtissues were co-cultured at a 1:1 ratio at an initial density of 6×10
5
 cells/ml in 
medium containing unstripped serum for 3, 5 or 7 days to assess gene expression over time.  To assess 
the effects of treatment with DHT or flutamide, microtissues were co-cultured at a 1:1 ratio at an 
initial density of 6×10
5
 cells/ml in medium containing stripped serum and either DHT (10 nM), 
flutamide (10 µM), DHT+flutamide or control medium for 4 days.  Microtissues were collected from 
hydrogels, pelleted and homogenized in Buffer RLT using 0.15 mm Zirconium Oxide Beads in the 
Bullet Blender Storm (Next Advance). RNA was then isolated using the RNeasy Mini Kit (Qiagen) 
per manufacturer’s instructions. For use in qRT-PCR, cDNA was made using the RT2 First Strand Kit 
(Qiagen) per manufacturer’s instructions. qRT-PCR was performed using RT2 SYBR Green Rox 
qPCR Mastermix with RT
2
 qPCR Primer Assays (Qiagen) to determine expression levels of AR 
(PPH01016A), estrogen receptor 1 (ESR1, PPH01001A), estrogen receptor 2 (ESR2, PPH00992C), 
and CYP1B1 (PPH00435F) and normalized to ribosomal protein, large, P0 (RPLP0, PPH21138F) and 
β-actin (ACTB, PPH00073G) using RT2 qPCR Primer Assay (Qiagen). Plates were run on an Applied 
Biosystems ViiA 7 machine using cycling conditions recommended by the manufacturer.  The mean 
CT for the target (ESR1, ESR2, AR, CYP1B1) genes and the geometric mean CT for the endogenous 
control (RPLP0 and ACTB) genes was calculated for each of the 4 independent experiments and the 
mean CT for the endogenous controls was subtracted from the mean CT for each target gene within 
each experiment to give the Δ Mean.  For timecourse experiments, the ΔCт Mean at days 5 or 7 were 
subtracted from the ΔCт Mean at day 3 to provide the ΔΔCт for that gene at each timepoint.  For the 
experiments using DHT and flutamide, the ΔCт Mean at each treatment (DHT, flutamide, or 
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DHT+flutamide) was subtracted from the control (untreated) ΔCт Mean to provide the ΔΔCт for each 
treatment. Finally, the ΔΔCт values were raised to the power of 2 (2-ΔΔCт) to provide the fold 
change in the target gene at each timepoint relative to day 3, or each treatment relative to control.  The 
mean of the 4 experiments was presented.  Data were analysed in GraphPad Prism using an ordinary 
one-way analysis of variance (ANOVA) followed by a multiple comparison test.  Tukey’s multiple 
comparison test was performed for the timecourse experiment (every timepoint vs. every other 
timepoint).  For the DHT and flutamide experiment, Dunnett’s multiple comparison test (each 
treatment vs. control) was performed. 
 
3. RESULTS 
Time-course experiments were conducted using medium containing normal (unstripped) FBS, to 
monitor the development of the microtissues at 3, 5 and 7 days after seeding.  Assessments on days 3, 
5 and 7 included morphology by confocal imaging and light microscopy, the expression of selected 
proteins using IHC, and qRT-PCR to monitor the expression of selected genes over time.  Following 
this initial characterization, a set of further experiments was conducted in which microtissues were 
grown in medium containing charcoal stripped FBS to remove background androgenic signals, and 
the response of the microtissues to treatment for 4 days with an androgen (DHT), an anti-androgen 
(flutamide) or a mixture of DHT+flutamide was assessed using the same evaluations. 
 
3.1. Morphology of untreated RWPE-1/WPMY-1 prostate microtissues 
After seeding in either medium containing standard or stripped FBS, the cells settled to the bottom of 
the recesses in the agarose gels (256 recesses per well) and self-assembled into spheroids over the 
course of 24-hours.  Confocal imaging showed untreated spheroids at early timepoints (up to 3 days) 
comprised a core of epithelial RWPE-1 cells adjacent to or surrounded by stromal WPMY-1 cells 
(Figure 1A).  By Day 5 after seeding, the untreated microtissues self-organized with a high proportion 
of spheroids consisting of an inner core of WPMY-1 cells surrounded by RWPE-1 cells (Figure 1B).  
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As the microtissues develop there is persistent arrangement of the epithelium on the surface of the 
mesothelium, with increased squamous metaplasia as the specimen ages (Figure 2).  The 
epithelium:stroma ratio of 1:1 was maintained throughout the culture period.  By day 5 scattered 
pyknotic nuclei were apparent in the stromal cells at the core of the microtissue, indicating cell death 
in this population of cells (Figure 2B).  By day 7 after seeding microtissues were approximately 200 
µm in diameter with a stromal core composed of both viable cells and nuclear debris indicative of cell 
loss (Figure 2C).  At day 7, in some instances, clusters of stromal cells not surrounded by epithelial 
cells were present and appeared viable (see Supplementary Figure S2 for representative micrographs). 
 
 
Figure 1. Confocal images of prostate co-culture microtissues. The co-cultures of epithelial RWPE-1 cells 
(yellow) and stromal WPMY-1 cells (green) were grown in medium containing charcoal-stripped serum for 3 
(A) or 5 (B) days and undergo a spontaneous re-arrangement so that by day 5 most microtissues consist of a 
core of WPMY-1 cells surrounded by RWPE-1 cells.  Scale bar = 2 mm. 
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3.2. Immunohistochemistry of untreated prostate microtissues 
IHC was performed to assess whether proteins expressed by the microtissues were reflective of 
normal human prostate tissue and to differentiate between the WPMY-1 and RWPE-1 cells.  Proteins 
detected using IHC are listed in Table 1, and representative micrographs are included in the 
Supplementary Material.  Of the cytokeratins (CKs) assessed, CK5/6 and CK14 were the most 
expressed in cuboidal epithelial cells, whereas the isolated cells staining for CK8 or 18 appeared 
squamous and were found on the surface of the microtissues.  Expression of CK5/6 and vimentin 
provided strong markers to differentiate RWPE-1 and WPMY-1 cells respectively (Figure 2) 
 
Table 1: Protein expression in prostate microtissues  
Protein RWPE-1 cells WPMY-1 cells 
CK5/6 ++ - 
CK8 + - 
CK14 ++ - 
CK18 + - 
CK19 + - 
PSA ++ - 
Vimentin - ++ 
- protein not detected 
+ low level detected 
++ high level detected 
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Figure 2. RWPE-1 cells in microtissue co-cultures grown in medium containing charcoal-stripped serum for 3, 
5 or 7 days express CK5/6 (D-F) and PSA (J-L), while WPMY-1 cells express vimentin (G-I).  The distribution 
of these markers confirms the spontaneous rearrangement of the microtissues over 5 days.  By day 5 stromal 
cells show pyknotic nuclei (B).  Scale bar = 100 µm. 
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3.3. Gene expression in untreated microtissues 
Expression of AR and CYP1B1 genes were stable over 7-days in medium containing unstripped 
serum, while ESR1 and ESR2 gene expression increased over this period (Figure 3). 
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Figure 3. qRT-PCR in microtissue co-cultures grown in medium containing normal serum for 3, 5 or 7 days.  
Expression of AR and CYP1B1 are stable over 7 days, whist ESR1 and ESR2 expression increases over time.  
Data represent 4 independent experiments.  Error bars show standard deviation.  p value = Tukey’s multiple 
comparisons test. 
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3.4. Effects of treatment with androgens and anti-androgens on morphology, protein and gene 
expression 
Microtissues were seeded (day 0) and continually treated with flutamide (10 µM), DHT (10 nM), or 
flutamide+DHT (10 µM+10 nM respectively) to assess the androgen responsiveness of the 
microtissues.  The assessments on treated tissues were conducted at day 4 after seeding, representing a 
time when the microtissues had self-organized and contained a viable stromal core.  
The predominant arrangement in the DMSO control group was of a single stromal core of WPMY-1 
cells surrounded by an epithelial layer of RWPE-1 cells, as demonstrated by IHC and confocal 
imaging (Figures 4A and 4B).  Treatment with flutamide resulted in an increase in microtissues with 
fragmented stromal cores and an increase in the proportion of epithelial cells (Figures 4C and 4D).  
Treatment with DHT alone did not cause an appreciable change in the cellular morphology or the 
arrangement of stromal and epithelial cells compared with control (Figures 4E and 4F). Treatment 
with DHT+flutamide resulted in an irregular and ill-formed microtissue, including an increased 
incidence of spheroids consisting of an epithelial core surrounded by stromal cells, and an increase in 
the proportion of epithelial cells (Figures 4G and 4H).  The day 4 flutamide+DHT microtissues 
showed an arrangement that was similar to the day 3 control microtissues (compare Figures 5D,5H, 
5L and 5P with Figures 2A, 2D, 2G and 2J respectively). 
Microtissues treated with DHT, flutamide or DHT+flutamide continued to express PSA.  
Qualitatively the PSA staining intensity varied with treatment, with the highest staining in control, 
followed by DHT, followed by flutamide with or without DHT (Figure 5M to 5P).  In addition, 
treatment with DHT+flutamide resulted in increased viability of the WPMY-1 stromal cells than 
either the control group or the individual treatments (Figure 5). 
DHT treatment was associated with a >2 fold increase in both ESR1 and ESR2 gene expression at day 
4, although only the ESR1 increase was significantly different to control (Figure 6).  DHT was also 
associated with a significant decrease in CYP1B1 expression.  
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Figure 4.  Immunohistochemical staining for CK5/6 (A, C, E, G) and confocal images (B, D, F, H) of prostate 
microtissue co-cultures. Prostate microtissues were exposed for 4 days to flutamide (C, D), DHT (E, F), or 
DHT+flutamide (G, H).  Flutamide causes an increased incidence of fragmented cores of WPMY-1 cells (green 
in confocal images) compared with control and DHT, whilst DHT+flutamide causes fewer microtissues with 
clearly defined WPMY-1 cores, and in many cases the core consists of RWPE-1 cells (yellow in confocal 
images). 
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Figure 5.  Expression of CK5/6 (E-H) vimentin (I-L), and PSA (M-P) in co-cultures exposed to flutamide (B, F, 
J, N), DHT (C, G, K, O), or DHT+flutamide (D, H, L, P) for 4 days.  The distribution of IHC markers confirms 
that treatment with DHT+flutamide affects the arrangement of the cell types.  Treatment results in variation in 
the PSA staining intensity with the highest staining in control, followed by DHT, followed by flutamide +/- 
DHT.  Scale bar = 100 µm. 
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Figure 6. qRT-PCR in microtissue co-cultures exposed to DHT, flutamide, or DHT+flutamide for 4 days.  DHT 
treatment resulted in significantly increased ESR1 expression and significantly decreased CYP1B1 expression.  
Data represent 4 independent experiments.  Error bars show standard deviation.  p value = Dunnett’s multiple 
comparisons test. 
 
4. DISCUSSION 
In healthy prostate tissue interactions between the stromal and epithelial compartments are necessary 
to maintain epithelial differentiation, highlighting the importance of the stroma to ensure a 
differentiated in vivo-like phenotype (Hayward, Rosen and Cunha, 1997).  Furthermore, androgenic 
stimulation of the stroma is an important trigger for development of the epithelium during 
organogenesis (Cunha, Donjacour and Sugimura, 1986; Peng and Joyner, 2015).  These observations 
led us to develop prostate microtissues composed of co-cultures of epithelial and stromal cell lines. 
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Normal human prostatic epithelium consists of a basal layer of flat to cuboidal non-secretory cells 
expressing CK5 and 14, upon which rests the luminal layer of cuboidal or pseudo-columnar cells 
expressing CK8 and 18 which secrete PSA into the prostatic acini (Gauntner and Prins, 2018). 
RWPE-1 and WPMY-1 cells seeded in agarose molds underwent spontaneous rearrangement to form 
spheroids consisting of a core of WPMY-1 (stromal) cells surrounded by RWPE-1 (epithelial) cells.  
The microtissues formed no ducts or acini but did secrete PSA.   
During fetal and neonatal development the expression of CKs in the prostatic epithelium undergoes 
significant change, moving from a predominant expression of CKs 5 and 14 (associated with basal 
epithelium), towards expression of CKs 8 and 18 (associated with luminal epithelium) (Sherwood et 
al., 1991; Xue et al., 1998). The epithelial cell layer of our microtissues exhibited characteristics of 
both the basal and luminal epithelium of normal human prostate, comprising mostly of cuboidal or 
flattened cells with high expression of CK5/6 and CK14, low expression of CK8, 18 and 19, and over 
time, high expression of PSA.  Several investigators have described such an ‘intermediate’ cell type in 
human prostatic epithelium which may develop into differentiated luminal cells (Sherwood et al., 
1991; Bonkhoff, Stein and Remberger, 1994), and others have observed that the majority of prostate 
epithelial cells in culture show this intermediate phenotype (Festuccia et al., 2005).  It therefore 
appears that the epithelial layer of RWPE-1/WPMY-1 co-cultures grown described here consist of 
intermediate cells, analogous to an early stage of prostate development. 
These microtissues expressed PSA in medium containing stripped serum, representing a virtually 
androgen-free environment (Figure 2J-L).  Previous studies of LNCaP cells in culture have suggested 
an ability of prostate cancer cells to auto-regulate the metabolism of testosterone to DHT to provide 
an optimal level of DHT for growth, even under castrate conditions (Sedelaar and Isaacs, 2009).  
Furthermore, RWPE-1 medium contains EGF, which can directly activate the AR in the absence of 
androgens (Culig et al., 1994).  These are the two most likely reasons why the untreated microtissues 
in medium containing stripped serum continued to express PSA.  Conversely, the observation that 
culture in 10 nM DHT resulted in microtissues that were histologically indistinct from control with 
minimal changes in AR gene expression may reflect that at this high concentration of DHT AR 
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receptors are desensitized and no longer being up-regulated.  Events at lower concentrations may 
therefore be very different. 
The interesting observation that administration of flutamide or a combination of DHT and flutamide 
affected the morphology of the microtissues in different ways implies that the spontaneous 
arrangement of these microtissues is affected by androgenic signalling.  Treatment with either 
flutamide or DHT+flutamide caused an increase in the proportion of epithelial to mesothelial cells 
present in the microtissues.  This observation warrants further investigation of the 
epithelial/mesothelial ratio as a biomarker of effect for (anti-)androgens, providing a quantitative 
measure to identify substance exposures that alter the development of the microtissues compared with 
control.  Treatment with DHT+flutamide resulted in microtissues at day 4 that resembled day 3 
control microtissues, both in terms of the relative arrangement of the epithelial and stromal cells and 
lower relative expression of ESR1 and ESR2.  This treatment therefore appeared to slow the 
development of the microtissue.  Although DHT administration alone did not affect the arrangement 
or proportion of cells in the microtissue, it was associated with a 2-fold increase in ESR1 and ESR2 
gene expression.  The fact that co-administration of flutamide resulted in ESR1 and ESR2 gene 
expression levels similar to control suggests that the increased ESR1 and ESR2 gene expression seen 
with DHT was related to AR binding.  There are inter-relationships between the functioning of AR 
and ESR1 and ESR2, and our results were consistent with previous studies in MCF-7 cells.  These 
showed that administration of DHT counteracts the proliferative activity of estradiol, an effect which 
is reversed by coadministration with the flutamide metabolite hydroxyflutamide  (Andò et al., 2002).  
DHT has been shown to not only bind to the ESR1, it also has inhibitory or stimulatory effects on the 
proliferation of breast cancer cell lines depending on the dose, cell line, and whether estradiol was 
present (Somboonporn and Davis, 2004; Lin et al., 2009).  Taken together, the increased ESR1 and 
ESR2 gene expression was likely a response to AR-mediated suppression of estrogenic signalling.  In 
breast cancer cell lines CYP1B1 expression is regulated by estradiol via ESR1 (Tsuchiya et al., 2004), 
which makes mechanistic sense because estradiol is a substrate for the CYP1B1 protein.  The reduced 
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CYP1B1 expression seen in our study was therefore likely due to the AR-mediated suppression of 
estrogenic signalling. 
ESR1 is an oncogene in prostatic tissue and is expressed in stromal cells and in the basal epithelium.  
ESR2 is a tumour suppressor gene which tends to be localised in luminal epithelial cells, and 
undergoes substantial loss in castration resistant prostate cancer (Bonkhoff, 2018).  A change in the 
relative expression of these genes could therefore provide predictive biomarkers for the development 
of prostate cancer.  Similarly, CYP1B1 is expressed at much higher levels in prostate tumours 
compared with benign tissue (Ragavan et al., 2004), and is also over-expressed in prostate cancer cell 
lines compared with RWPE-1 cells (Chang et al., 2017).  These genes may therefore also be useful 
biomarkers to assess the transition from an adaptive to an adverse response to xenobiotics. 
The decreased viability of the WPMY-1 cells after 4 days of culture in this system is a significant 
limitation.  Optimization of culture conditions is therefore required to establish whether extended 
period in culture with a viable stromal compartment would increase the proportion of epithelial cells 
more reflective of a differentiated luminal phenotype.  The WPMY-1 cells at the core of the 
microtissues were less viable than those on the outside (see Supplementary Materials for 
micrographs).  Necrosis at the center of larger (>200µm) spheroids due to hypoxia is a well described 
phenomenon (Däster et al., 2017).  However, because poor viability was apparent in areas very close 
to the outside edge of our microtissues and not just at the center this does not seem a likely cause.  
Mechanical stress upon core cells in spheroids grown in agarose molds has also been reported (Cheng 
et al., 2009), but again this appears to affect much larger microtissues.  It is unclear whether the 
WMPY-1 cells at the core of the microtissue showed poor viability because they were enclosed by the 
RWPE-1 cells or were enclosed because they were showing poor viability.  Although the order of 
events is not yet clear, it does appear that the viability of WPMY-1 cells in co-culture relies on a 
specific level of androgenic stimulation, because co-administration of DHT and flutamide resulted in 
improved viability of these cells at day 4. 
In summary, RWPE-1 and WPMY-1 cells formed microtissues when grown in scaffold-free 
hydrogels.  The proteins detected by immunohistochemistry indicated that the microtissues reflected 
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an early stage of human prostate development.  Morphological and molecular biomarkers including 
the arrangement of the stromal and epithelial compartments, expression of PSA, and gene expression 
showed that the microtissues were responsive to androgens and anti-androgens.  Long-term viability 
of the WPMY-1 cells in co-culture relies on a specific level of androgenic stimulation, and future 
work will include a dose-response study with a broad range of DHT concentrations to test this 
hypothesis.  The utility of the biomarkers described will also further be investigated, in particular, the 
use of automated confocal microscopy using the Opera Phenix system to provide quantitative readouts 
of cellular distribution and morphology.  
 
5. CONCLUSION 
For a prostate microtissue to be useful in non-animal next generation risk assessment, it needs to be 
able to bridge the gap between in vitro studies providing a readout of ‘endocrine activity’ (e.g. 
transcriptional activation) and in vivo studies which characterize apical outcomes (i.e. observed 
pathology).  To do this requires the development of a human-relevant microtissue and the 
identification of molecular and morphological biomarkers that are predictive of adverse effects.  With 
further development and optimization RWPE-1/WPMY-1 microtissues can play an important role in 
non-animal risk assessments. 
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LIST OF FIGURES 
Figure 1. Confocal images of prostate co-culture microtissues. The co-cultures of epithelial RWPE-1 
cells (yellow) and stromal WPMY-1 cells (green) were grown in medium containing charcoal-
stripped serum for 3 (A) or 5 (B) days and undergo a spontaneous re-arrangement so that by day 5 
most microtissues consist of a core of WPMY-1 cells surrounded by RWPE-1 cells.  Scale bar = 2 
mm. 
Figure 2. RWPE-1 cells in microtissue co-cultures grown in medium containing charcoal-stripped 
serum for 3, 5 or 7 days express CK5/6 (D-F) and PSA (J-L), while WPMY-1 cells express vimentin 
(G-I).  The distribution of these markers confirms the spontaneous rearrangement of the microtissues 
over 5 days.  By day 5 stromal cells show pyknotic nuclei (B).  Scale bar = 100 µm. 
Figure 3. qRT-PCR in microtissue co-cultures grown in medium containing normal serum for 3, 5 or 
7 days.  Expression of AR and CYP1B1 are stable over 7 days, whist ESR1 and ESR2 expression 
increases over time.  Data represent 4 independent experiments.  Error bars show standard deviation.  
p value = Tukey’s multiple comparisons test. 
Figure 4.  Immunohistochemical staining for CK5/6 (A, C, E, G) and confocal images (B, D, F, H) of 
prostate microtissue co-cultures. Prostate microtissues were exposed for 4 days to flutamide (C, D), 
DHT (E, F), or DHT+flutamide (G, H).  Flutamide causes an increased incidence of fragmented cores 
of WPMY-1 cells (green in confocal images) compared with control and DHT, whilst DHT+flutamide 
causes fewer microtissues with clearly defined WPMY-1 cores, and in many cases the core consists of 
RWPE-1 cells (yellow in confocal images). 
Figure 5.  Expression of CK5/6 (E-H) vimentin (I-L), and PSA (M-P) in co-cultures exposed to 
flutamide (B, F, J, N), DHT (C, G, K, O), or DHT+flutamide (D, H, L, P) for 4 days.  The distribution 
of IHC markers confirms that treatment with DHT+flutamide affects the arrangement of the cell 
types.  Treatment results in variation in the PSA staining intensity with the highest staining in control, 
followed by DHT, followed by flutamide +/- DHT.  Scale bar = 100 µm. 
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Figure 6. qRT-PCR in microtissue co-cultures exposed to DHT, flutamide, or DHT+flutamide for 4 
days.  DHT treatment resulted in significantly increased ESR1 expression and significantly decreased 
CYP1B1 expression.  Data represent 4 independent experiments.  Error bars show standard deviation.  
p value = Dunnett’s multiple comparisons test. 
 
Supplementary figures: 
Figure S1. Cytokeratin expression in microtissue co-cultures grown in complete medium for 3, 5 or 7 
days.  Predominant CK expression is CK5/6 and CK14.  Few, scattered cells show staining for CKs 8, 
18 or 19.  Scale bar = 100 µm. 
Figure S2.  Microtissues grown in medium containing stripped serum for 7 days and stained for 
CK5/6 expression. WPMY-1 cells on the outside of microtissues show improved survival compared 
with those in the core at 7 days after seeding. Scale bar = 100 µm. 
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HIGHLIGHTS 
 
- Non-animal risk assessment requires innovative cellular models representative of human 
biology 
- RWPE-1 and WPMY-1 cells form microtissues when grown in scaffold-free hydrogels 
- Microtissues represent an early stage of human prostate development 
- Morphological and molecular biomarkers are responsive to androgens/anti-androgens 
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